Busca avançada
Ano de início
Entree
(Referência obtida automaticamente do Web of Science, por meio da informação sobre o financiamento pela FAPESP e o número do processo correspondente, incluída na publicação pelos autores.)

A Catalytically Inactive Lys49 PLA2 Isoform from Bothrops jararacussu venom that Stimulates Insulin Secretion in Pancreatic Beta Cells

Texto completo
Autor(es):
Fagundes, Fabio H. R. [1, 2] ; Aparicio, Ricardo [3] ; dos Santos, Marcelo L. [3] ; Diz Filho, Eduardo B. S. [1, 2] ; Oliveira, Simone C. B. [1, 2] ; Toyama, Daniela O. [4] ; Toyama, Marcos H. [1, 2]
Número total de Autores: 7
Afiliação do(s) autor(es):
[1] UNESP, Sao Vicente - Brazil
[2] UNICAMP SP, IB, Dept Bioquim, Campinas, SP - Brazil
[3] UNICAMP SP, Inst Quim, Campinas, SP - Brazil
[4] Univ Mackenzie SP, Ctr Ciencias Biol & Saude, Sao Paulo - Brazil
Número total de Afiliações: 4
Tipo de documento: Artigo Científico
Fonte: PROTEIN AND PEPTIDE LETTERS; v. 18, n. 11, p. 1133-1139, NOV 2011.
Citações Web of Science: 6
Resumo

A new secretory phospholipase A2 (sPLA2) isoform from Bothrops jararacussu venom (BjVIII) has been characterized by causing platelet aggregation, an absent activity in BthTx-I, Prtx-I and PrTx-II sPLA2s. According to our results, BjVIII also enhances insulin release by the pancreatic beta cells. The complete amino acid sequence of the new isoform was determined by Edman degradation and de novo peptide sequencing. These analyses showed a G35K amino acid modification for BjVIII in comparison with BthTx-I, PrTx-I and Prtx-II, a structural difference that has been related to the conflicting biological activities among BjVIII and other Lys49 sPLA2s. The whole set of evidences collected in this work indicates that, besides the C-terminal region and B-wing of PLA2, the calcium binding loop in BjVIII should be considered as an important region, involved in the pharmacological effects of Lys49-sPLA2 isoforms from the Bothrops genus. (AU)

Processo FAPESP: 07/54714-3 - Avaliacao da fosfolipase a2 secretorias na infeccao experimental causada por leishmania (leishmania) amazonensis.
Beneficiário:Marcos Hikari Toyama
Modalidade de apoio: Auxílio à Pesquisa - Regular